We now provide proof-of-concept that disrupting TGFBI-ZEB1 signaling not only increased CIN, but functioned much like a BRCA mutation by increasing sensitivity to PARP inhibition. The gene discussed is TGFBI; the disease is cervical squamous intraepithelial neoplasia.